XML 37 R17.htm IDEA: XBRL DOCUMENT v3.24.1
Notes to the Consolidated Statements of Financial Position (Tables)
12 Months Ended
Dec. 31, 2023
Notes to the Consolidated Statements of Financial Position [Abstract]  
Schedule of Property and Equipment Property and equipment
   Property
and
equipment
   Advance
payments
   Total 
Cost  (in €) 
At January 1, 2022   1,267,611    
       —
    1,267,611 
Additions   160,491    
    160,491 
Exchange differences   25,236    
    25,236 
At December 31, 2022   1,453,339    
    1,453,339 
Additions   55,123    
    55,123 
Disposals   (2,595)   
    (2,595)
Exchange differences   (14,342)   
    (14,342)
At December 31, 2023   1,491,525    
    1,491,525 
                
Accumulated depreciation               
At January 1, 2022   (993,238)   
    (993,238)
Depreciation charge for the year   (113,894)   
    (113,894)
Exchange differences   (17,286)   
    (17,286)
At December 31, 2022   (1,124,419)   
    (1,124,419)
Depreciation charge for the year   (93,791)   
    (93,791)
Disposals   2,594    
    2,594 
Exchange differences   13,668    
    13,668 
At December 31, 2023   (1,201,948)   
    (1,201,948)
                
Net book value               
At December 31, 2022   328,920    
    328,920 
At December 31, 2023   289,577    
    289,577 

 

Schedule of Right-of-Use Assets Right-of-use assets
   Buildings   Cars   Total 
Cost  (in €) 
At January 1, 2022   2,284,269    125,130    2,409,399 
Additions   281,429    
    281,429 
Exchange differences   13,645    
    13,645 
At December 31, 2022   2,579,342    125,130    2,704,473 
Additions   91,125    49,004    140,128 
Exchange differences   (9,349)   
    (9,349)
At December 31, 2023   2,661,118    174,134    2,835,253 
                
Accumulated depreciation               
At January 1, 2022   (925,306)   (76,015)   (1,001,321)
Depreciation charge for the year   (354,408)   (30,024)   (384,432)
Exchange differences   (6,911)   
    (6,911)
At December 31, 2022   (1,286,625)   (106,039)   (1,392,664)
Depreciation charge for the year   (353,398)   (24,527)   (377,925)
Exchange differences   7,003    
    7,003 
At December 31, 2023   (1,633,020)   (130,566)   (1,763,586)
                
Net book value               
At December 31, 2022   1,292,717    19,092    1,311,809 
At December 31, 2023  1,028,098   43,568   1,071,666 
Schedule of Intangible Assets Intangible Assets
   Purchased
IT-software
   Advances
paid for
software
   Total 
Cost  (in €) 
At January 1, 2022   720,942    
    720,942 
Additions   1,900    
    1,900 
Exchange differences   408    
    408 
At December 31, 2022   723,250    
    723,250 
Additions   
    25,977    25,977 
Disposals   (7,009)   
    (7,009)
Exchange differences   (111)   
    (111)
At December 31, 2023   716,130    25,977    742,107 
                
Accumulated amortization               
At January 1, 2022   (485,726)   
    (485,726)
Amortization charge for the year*   (98,271)   
    (98,271)
Exchange differences   (348)   
    (348)
At December 31, 2022   (584,345)   
    (584,345)
Amortization charge for the year   (96,063)   
    (96,063)
Disposals   7,009    
    7,009 
Exchange differences   111    
    111 
At December 31, 2023   (673,289)   
    (673,289)
                
Net book value               
At December 31, 2022   138,905    
    138,905 
At December 31, 2023  42,841   25,977   68,818 
Schedule of Lease Liabilities Set out below, are the carrying amounts and the movements of the Group’s lease liabilities:
Lease liabilities  2023   2022 
   (in €) 
As of January 1   1,356,684    1,432,526 
Additions   140,128    281,429 
Derecognition   (20,555)   (20,555)
Payments   (353,422)   (343,874)
Short-term liability for accrued interest expense   (396)   304 
Foreign exchange difference   (2,391)   6,854 
As of December 31   1,120,048    1,356,684 
Schedule of Amounts Recognized in Profit or Loss The following are the amounts recognized in profit or loss:
   2023   2022   2021 
   (in €) 
Depreciation expense of right-of-use assets (see Note E.2.)   377,925    384,432    371,551 
Interest expense on lease liabilities   19,090    21,947    14,055 
Rental expense from leases   6,261    6,261    6,261 
Thereof short-term leases (included in administrative expenses)   
 
    
    
 
Thereof leases of low-value assets (included in administrative expenses)   6,261    6,261    6,261 
Total amounts recognized in profit or loss   403,276    412,640    391,867 
Schedule of Inventory Inventory
   2023   2022   2021 
   (in €) 
Raw material and supplies   423,560    
       —
    
      —
 
Unfinished goods   10,614,159    
    
 
Finished goods   330,087    
    
 
Total   11,367,807    
    
 
Schedule of Other Assets Other assets
   December 31,
2023
   December  31, 2022 
   (in €) 
Non-current other assets        
Prepaid expenses   257,267    308,066 
Total   257,267    308,066 
Current other assets          
Prepayments on research & development projects   3,670,167    9,776,505 
Prepaid expenses   272,999    1,841,935 
Others   93,482    2,552,071 
Total   4,036,648    14,170,511 
Total other assets   4,293,915    14,478,577 
Schedule of Applicable Tax Rate and Current Income Taxes Recognized in Profit or Loss The table below shows a reconciliation between the product of loss before tax multiplied by the Company’s applicable tax rate and current income taxes recognized in profit or loss.
InflaRx Group  2023   2022   2021 
       (in €)     
Loss for the period (accounting profit before income tax)   (42,667,529)   (29,484,611)   (45,630,059)
Tax rate   28.6%   29.2%   28.5%
Tax benefits at tax rate   12,160,545    8,610,381    13,001,984 
Temporary differences and tax losses for which no deferred tax asset was recognized   (12,127,977)   (7,480,169)   (10,988,805)
Non-recognition of tax effect on share-based payments   (32,182)   (1,251,830)   (1,959,606)
Non-deductible expenses for tax purposes   (46,907)   (22,067)   (3,758)
Other differences due to tax rate   46,521    143,686    (49,815)
Income tax   
    
    
 
Schedule of Financial Assets and Liabilities Set out below is an overview of financial assets and liabilities, other than cash and short-term deposits included in cash equivalents, held by the Group as at December 31, 2023 and December 31, 2022:
Financial assets and financial liabilities  December 31,
2023
   December 31,
2022
 
   (in €) 
Financial assets at amortized cost        
Non-current financial assets   9,052,741    2,900,902 
Financial assets from government grants   
    732,971 
Other current financial assets   77,504,518    64,791,088 
Financial liabilities at amortized cost          
Liabilities from government grants   
    6,209,266 
Trade and other payables   14,716,441    4,987,538 
Schedule of Cash and Cash Equivalents Cash and cash equivalents
   December 31,
2023
   December 31,
2022
 
   (in €) 
Short-term deposits        
Deposits held in U.S. dollars   4,120,951    3,422 
Deposits held in Euro   1,020,000    
 
Total   5,140,951    3,422 
Cash at banks          
Cash held in U.S. dollars   5,041,802    8,645,014 
Cash held in Euro   2,585,190    7,616,918 
Total   7,626,991    16,261,932 
Total cash and cash equivalents   12,767,942    16,265,354 
Schedule of Trade and Other Payables Trade and other payables
   December 31,
2023
   December 31,
2022
 
   (in €) 
Accrued liabilities from R&D projects   4,414,143    2,254,550 
Accrued liabilities from commercial activities   1,400,382    
 
Accounts payable   5,102,700    1,566,400 
Other accrued liabilities and payables   3,942,909    1,314,196 
Total trade and other payables   14,860,134    5,135,146 
Schedule of Market Risk, Credit Risk and Liquidity Risk The Group is exposed to market risk, credit risk and liquidity risk. The Board of Directors reviews and adopts policies for managing each of these risks, which are summarized below. The Group’s senior management oversees the management of these risks.
  Exposure Measurement Risk Management
Market risk Future development costs; Recognized financial assets and liabilities not denominated in Euro Forecasted cash flows Sensitivity analysis

Achievement of a natural hedge

in the future

Credit risk

Cash and cash equivalents,

current and non-current
financial assets

Credit

rating

Diversification of bank deposits, Investment guidelines for

debt investments

Liquidity R&D and G&A cost, equity, trade and other payables

Rolling

cash flow forecast

Availability of funds through financing rounds or public offerings
Schedule of Cash, Cash Equivalents and Financial Assets In 2023, if the Euro had weakened/strengthened by 10% against the U.S. dollar with all other variables held constant, the Group’s loss would have been €1 million higher/€1 million lower, mainly as a result of foreign exchange on translation of U.S. dollar-denominated assets of InflaRx N.V. and InflaRx GmbH.
Cash, cash equivalents and financial assets denominated in U.S. dollars, InflaRx N.V. and InflaRx GmbH  December 31,
2023
   December 31,
2022 *
 
   (in €) 
Current and non current financial assets (securities and accrued interest)   80,935,197    7,376,866 
Cash and cash equivalents   8,051,366    4,356,512 
Total assets exposed to the risk   88,986,563    11,733,378 
Conversion rate Euro to U.S. dollars at reporting date 1/1.1050           
*The 2022 figures do not include InflaRx N.V. given the 2022 functional currency was in USD.
Schedule of Sensitivity Analysis
Sensitivity analysis:  Conversion
rate
   Profit/(loss)   carrying
amount
 
       (in €)     
Euro weakens against U.S. dollars   1.2155    9,887,396    98,873,959 
Euro strengths against U.S. dollars   0.9945    (8,089,688)   80,896,875 
Schedule of Outstanding Financial Commitments At the end of the reporting period, the Group held the following deposits that are expected to readily generate cash inflows to meet the outstanding financial commitments.
Liquidity  December 31,
2023
   December 31,
2022
 
   (in €) 
Short-term deposits   5,140,951    3,422 
Cash at banks   7,626,992    16,261,932 
Marketable Securities (current and non-current)   85,727,461    67,175,879 
Other (non-current portion)   237,621    237,296 
Other (current)   701,407    278,815 
Total funds available   99,434,432    83,957,344